Eriko Simamura
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Clinical Biochemistry top 10%
- Metabolism and Genetic Disorders
Papers in
-
- ATP Synthase and ATPases Research 4
- Cell death mechanisms and regulation 2
- Heme Oxygenase-1 and Carbon Monoxide 2
- Cancer therapeutics and mechanisms 2
-
- Bioactive Compounds and Antitumor Agents 6
- Co-authors
- Kei‐Ichi Hirai (12 shared papers)Hiroki Shimada (14 shared papers)Toshihisa Hatta (10 shared papers)Junko Koyama (6 shared papers)Jiehong Pan (5 shared papers)Nobuaki Higashi (4 shared papers)Shigeomi Shimizu (2 shared papers)Yukie Niwa (1 shared paper)
- Journals
- Anatomical Science International (2 papers)Archives of Biochemistry and Biophysics (2 papers)PLoS ONE (2 papers)Endocrinology (1 paper)British Journal of Haematology (1 paper)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Eriko Simamura
22 papers receiving 540 citations
Peers
Comparison fields: 5 of 84
- Toxicology 70
- Clinical Biochemistry 39
- Molecular Biology 273
- Cancer Research 51
- Behavioral Neuroscience 12
Countries citing papers authored by Eriko Simamura
This map shows the geographic impact of Eriko Simamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eriko Simamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eriko Simamura more than expected).
Fields of papers citing papers by Eriko Simamura
This network shows the impact of papers produced by Eriko Simamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eriko Simamura. The network helps show where Eriko Simamura may publish in the future.
Co-authors
The 25 scholars most cited alongside Eriko Simamura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 78 | |
| 2 | 2006 | 69 | |
| 3 | 2008 | 69 | |
| 4 | 2010 | 40 | |
| 5 | 1998 | 33 | |
| 6 | 2008 | 29 | |
| 7 | 2015 | 28 | |
| 8 | 2009 | 22 | |
| 9 | 2006 | 21 | |
| 10 | 2002 | 18 | |
| 11 | 2011 | 17 | |
| 12 | 2001 | 16 | |
| 13 | 2015 | 15 | |
| 14 | 2005 | 14 | |
| 15 | 2003 | 14 | |
| 16 | 2008 | 13 | |
| 17 | 2012 | 13 | |
| 18 | 2002 | 12 | |
| 19 | 1997 | 10 | |
| 20 | Induced apoptosis and necrosis by 2-methylfuranonaphthoquinone in human cervical cancer HeLa cells. | 2000 | 10 |
About Eriko Simamura
Eriko Simamura is a scholar working on Molecular Biology, Toxicology, Immunology, Surgery and Oncology, having authored 22 papers that have together received 551 indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (6 papers), Paraquat toxicity studies and treatments (4 papers), ATP Synthase and ATPases Research (4 papers), Reproductive System and Pregnancy (3 papers), Galectins and Cancer Biology (2 papers), Cell death mechanisms and regulation (2 papers), Heme Oxygenase-1 and Carbon Monoxide (2 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Toxicology (70 citations), Clinical Biochemistry (39 citations), Molecular Biology (273 citations), Cancer Research (51 citations) and Behavioral Neuroscience (12 citations). Eriko Simamura has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Kei‐Ichi Hirai, Hiroki Shimada, Toshihisa Hatta, Junko Koyama, Jiehong Pan, Nobuaki Higashi, Shigeomi Shimizu, Yukie Niwa, Hiroki Otani and Tsutomu Takegami. Their work appears in journals such as Anatomical Science International, Archives of Biochemistry and Biophysics, PLoS ONE, Endocrinology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.